3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Lung Neoplasms
6
Small Cell Lung Carcinoma
2
Neoplasms
2
Triple Negative Breast Neoplasms
1
Thymoma
1
Small Cell Lung Cancer Limited Stage
1
Mesothelioma, Malignant
1
Melanoma
1
Limited Stage Small Cell Lung Cancer
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
pembrolizumab
12
Gemcitabine
9
Cetuximab
7
Psychiatric Rehabilitation
6
Paclitaxel
6
Magnetic Resonance Spectroscopy
6
Fluorouracil
6
Early Intervention, Educational
6
Cisplatin
6
cediranib
5
Leucovorin
5
Carboplatin
5
sargramostim
4
Standard of Care
4
Oxaliplatin
4
Methods
4
Erlotinib Hydrochloride
4
Docetaxel
4
Cyclophosphamide
4
selpercatinib
3
aldesleukin
3
adagrasib
3
Trastuzumab
3
Therapeutics
3
Pemetrexed
3
Nivolumab
3
Irinotecan
3
Fluorodeoxyglucose F18
3
Bortezomib
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Radiation Dose Hypofractionation
×
Thoracic
×
Clear all
NCT01936961
2017-06-27
I-CREST
Western Regional Medical Center
Phase NA
Withdrawn